Prestige Consumer Healthcare (PBH) EPS (Diluted) Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) EPS (Diluted) Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.46% |
| Sep 30, 2025 | -21.22% |
| Jun 30, 2025 | -2.42% |
| Mar 31, 2025 | 1.55% |
| Dec 31, 2024 | 15.36% |
| Sep 30, 2024 | 1.70% |
| Jun 30, 2024 | -8.03% |
| Mar 31, 2024 | 120.44% |
| Dec 31, 2023 | 2.23% |
| Sep 30, 2023 | 5.36% |
| Jun 30, 2023 | -2.59% |
| Mar 31, 2023 | -570.66% |
| Dec 31, 2022 | 5.00% |
| Sep 30, 2022 | 13.75% |
| Jun 30, 2022 | -4.41% |
| Mar 31, 2022 | 45.98% |
| Dec 31, 2021 | 21.95% |
| Sep 30, 2021 | 1.39% |
| Jun 30, 2021 | 32.50% |
| Mar 31, 2021 | -3.12% |